Koninklijke Philips N.V.
NYSE:PHGMedical - Devices
+$0.57 today
- Market cap
- $29.11B
- Beta
- 0.93
- P/E (TTM)
- 23.1
- EPS (TTM)
- $1.02
- Dividend yield
- 3.62%
Volume 1.45M
Average 1.17M
PHG Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
Koninklijke Philips N.V.NYSE: PHG
Investing Cash Flow · Q2 FY2026 · quarter ended Jun 2026
Investing cash flow dips below year-ago levels
Q2 FY2026 investing cash flow of €19M (cash outflow) fell 91.6% year over year, behind the +96.0% change in trailing-twelve-month investing cash flow. Sequentially, it fell 95.4% from the prior quarter. Over 3 fiscal years it compounded at -22.4% a year.
Context
- Investing cash flow amounted to 4.1% of revenue in FY2025, up 0.6 pp from a year earlier.
- Investing cash flow grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -91.6% toward the trailing-twelve-month pace of +96.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
EUR · from the cash flow
- Latest · FY2025
- (737M) EUR
- Year-over-year change
- -16.3%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (737M) | -16.3% |
| FY2024 | 2024-12-31 | (633.87M) | -14.5% |
| FY2023 | 2023-12-31 | (553.53M) | +64.9% |
| FY2022 | 2022-12-31 | (1.58B) | -395.5% |
| FY2021 | 2021-12-31 | (317.95M) | — |
Investing Cash Flow vs competitors
How PHG compares with its peers on the latest reported figures
- Peers report in different currencies, so investing cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +96.0% is the 4th highest of 10, against a peer median of +59.9%.
- Investing cash flow amounts to 4.4% of revenue for PHG, versus a peer median of 10.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $22.37B USD | +790.4% | +11.7% | 48.0% | |
| LTM Jul 2026 | $3.83B USD | +59.9% | -5.6% | 10.2% | |
| LTM Jun 2026 | $3.56B USD | -47.3% | +9.5% | 17.0% | |
| LTM Jun 2026 | $3.03B USD | +201.1% | +38.0% | 15.0% | |
| LTM Jun 2026 | €785.68M EUR | +96.0% | -22.4% | 4.4% | |
| LTM Jun 2026 | $706.75M USD | +253.3% | -22.2% | 12.5% | |
| FY2025 | $406M USD | -28.6% | -4.9% | 6.6% | |
| LTM Sep 2026 | $99.76M USD | +86.9% | +23.8% | 6.6% | |
| LTM Mar 2026 | $4.97M USD | -59.4% | +83.0% | 5.8% | |
| LTM Mar 2026 | $412K USD | -106.3% | — | 0.4% | |
| Peer median (excluding PHG) | — | +59.9% | +10.6% | 10.2% | |
Competitors are the stored peer set for PHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 718.64M | (1.7B) | (492.99M) | (912.95M) | 895M |
| Depreciation & Amortization | 1.32B | 1.6B | 1.26B | 1.39B | 1.13B |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 141M |
| Change in Working Capital | (179.66M) | (1.24B) | 1.51B | 7.57M | (1.33B) |
| Accounts Receivables | 0 | (359.43M) | 322.17M | (1.08M) | (9M) |
| Inventory | (686.73M) | (601.16M) | 277.85M | 248.79M | (115M) |
| Accounts Payables | 258.85M | 54.65M | 387.04M | (630.63M) | 0 |
| Other Working Capital | 248.22M | (337.36M) | 518.94M | 390.49M | (1.21B) |
| Other Non-Cash Items | 64.65M | 1.16B | 35.26M | 1.21B | 330M |
| Operating Cash Flow | 1.93B | (181.82M) | 2.31B | 1.7B | 1.16B |
| Capital Expenditures | (469.25M) | (466.63M) | (371.9M) | (342.9M) | (269M) |
| Acquisitions (Net) | (3.5B) | (600.11M) | 104.87M | 141.7M | (3M) |
| Purchases of Investments | (146.57M) | (197.58M) | (149.19M) | (133.05M) | 0 |
| Sales of Investments | 203.3M | 81.98M | 51.89M | 61.66M | 0 |
| Other Investing Activities | 4.02B | (12.61M) | 134.06M | 27.04M | (465M) |
| Investing Cash Flow | (317.95M) | (1.58B) | (553.53M) | (633.87M) | (737M) |
| Debt Repayment | (296.68M) | 1.15B | (195.68M) | (88.7M) | 448M |
| Common Stock Issued | 27.19M | 12.61M | 0 | 0 | 0 |
| Common Stock Repurchased | (1.93B) | (196.53M) | (715.7M) | (444.57M) | 0 |
| Dividends Paid | (569.71M) | (433M) | (2.16M) | (1.08M) | (328M) |
| Other Financing Activities | (2.36M) | (6.31M) | (3.24M) | (2.16M) | (13M) |
| Financing Cash Flow | (2.77B) | 525.49M | (916.79M) | (536.52M) | 107M |
| Effect of Forex Changes | (162.77M) | (136.41M) | (25.17M) | (105.14M) | (139M) |
| Net Change in Cash | (1.33B) | (1.37B) | 813.77M | 421.64M | 393M |
| Free Cash Flow | 1.46B | (648.45M) | 1.94B | 1.35B | 893M |
Koninklijke Philips N.V.
NYSE:PHG
Intrinsic Alpha fair value
Locked
Current Price
$29.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.